Exclusive content, detailed data sets, and best-in-class trade insights to rewrite your portfolio for tomorrow.
Try it NowFebruary 28, 2025 — 9:15 AM - 9:45 AM ET
Nasdaq MarketSite, 4 Times Square, New York
Rocket Pharmaceuticals, Inc. (Nasdaq: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, visits the Nasdaq MarketSite in Times Square.
In honor of the occasion, Gaurav Shah, M.D., Chief Executive Officer, Rocket Pharma, rings the Opening Bell.
Please try using other words for your search or explore other sections of the website for relevant information.
Our team is working diligently to resolve the issue. Thank you for your patience and understanding.
%20Dividend%20History%20%7C%20Nasdaq&_biz_n=1&rnd=352298&cdn_o=a&_biz_z=1743431026664)
%20Insider%20Activity%20%7C%20Nasdaq&_biz_n=2&rnd=111453&cdn_o=a&_biz_z=1743431026665)
%20Insider%20Activity%20%7C%20Nasdaq&_biz_n=3&rnd=821073&cdn_o=a&_biz_z=1743431026665)
